Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 73 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
721 14.5 months metastatic breast cancer 4 Chemotherapy
Uludag University Medical School Turkey 11/2005
Treatment Details: Patients: This Phase II study involved 26 women with metastatic breast cancer. The mean age was 47.3 years. Metastatic sites included bone, liver, and lung. All women had prior anthracycl
 
722 14.5 months Metastatic Colorectal Cancer 4 Radiation
Northwestern Memorial Hospital United States 5/2009
Treatment Details: Patients: There were 72 patients with liver-dominant colorectal metastases in this trial and 65% were male. The median age was 61 years with a range of 54-86 years. Treatment: Patients
 
723 14.5 months Metastatic colorectal cancer 5 Chemotherapy
Antwerp University Hospital Belgium 11/2010
Treatment Details: Patients: This phase III study involved patients with metastatic colorectal cancer who had previously received chemotherapy. Patients were divided into two separate treatment groups. Grou
 
724 14.5 months Advanced renal cell carcinoma 5 Biologic therapy
Chemotherapy
Princess Margaret Hospital Canada 6/2007
Treatment Details: Patients: This phase II study involved 32 patients with progressive, locally advanced, or metastatic renal cell carcinoma. The median age was 62 years, ranging from 46 to 76. The majority
 
725 14.5 months Hormone refractory prostate cancer 4 Chemotherapy
Centre Jean Perrin France 2/2006
Treatment Details: Patients: This Phase II study involved 40 men with metastatic hormone-refractory prostate cancer. None of the patients had chemotherapy before the study. The patients were randomized into
 
726 14.5 months kidney (metastatic) 4 Chemotherapy
University of Chicago United States 9/2006
Treatment Details: Patients: This phase II study involved 60 patients with metastatic kidney cancer, four of which did not did not start the treatment. Forty-three were men and 13 were women, with ages rangin
 
727 14.5 months Peripheral T-cell lymphoma 5 Biologic therapy
New York University Langone Medical Center United States 3/2011
Treatment Details: Patients: This study involved 111 patients with peripheral T-cell lymphoma (a subtype of non-Hodgkin’s lymphoma). The average patient age was 57.7 years and 68% were male. Treatment: P
 
728 14.5 months NHL 4 Chemotherapy
Hormone
University of Southern California United States 2/2007
Treatment Details: Patients: This study involved 19 non-Hodgkin’s lymphoma patients with a median age of 50 years; 47% were male. Treatment: Patients were treated with the chemotherapy agents pixantrone,
 
729 14.5 months Advanced NSCLC 4 Chemotherapy
Yonsei University College of Medicine Korea 7/2012
Treatment Details: Patients: This phase II study involved patients with advanced non-small-cell lung cancer with no prior chemotherapy who were divided into four separate treatment groups. Group A had 37 pat
 
730 14.4 months Advanced hepatocellular carcinoma 5 Biologic therapy
University of Bologna Italy 4/2014
Treatment Details: Patients: This study involved previously untreated advanced hepatocellular cancer patients who were divided into two separate treatment groups. Group A consisted of 74 patients with an ave
 
Page 73 of 187  | Previous Page  | Next Page